1. Home
  2. DRIO vs NA Comparison

DRIO vs NA Comparison

Compare DRIO & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

N/A

Current Price

$5.52

Market Cap

56.8M

Sector

Health Care

ML Signal

N/A

NA

Nano Labs Ltd

N/A

Current Price

$2.19

Market Cap

51.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DRIO
NA
Founded
2011
2019
Country
United States
China
Employees
165
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
56.8M
51.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
DRIO
NA
Price
$5.52
$2.19
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $13.60
N/A
AVG Volume (30 Days)
14.7K
★ 32.6K
Earning Date
11-12-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1559.02
N/A
EPS
★ 1.75
N/A
Revenue
★ $7,394,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$38.77
N/A
P/E Ratio
$3.10
★ N/A
Revenue Growth
★ 43.02
N/A
52 Week Low
$5.43
$1.58
52 Week High
$16.50
$5.97

Technical Indicators

Market Signals
Indicator
DRIO
NA
Relative Strength Index (RSI) 39.32 46.10
Support Level N/A $1.64
Resistance Level $8.01 $2.44
Average True Range (ATR) 0.39 0.12
MACD -0.09 -0.03
Stochastic Oscillator 24.57 8.33

Price Performance

Historical Comparison
DRIO
NA

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: